| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/20/2013 | WO2013089157A1 Oligonucleotide and therapeutic agent for hyperlipidemia containing same as active ingredient |
| 06/20/2013 | WO2012031097A9 Molecular markers associated with yellow flash in glyphosate tolerant soybeans |
| 06/20/2013 | WO2008045970A9 Compositions and methods of using chondroitinase abci mutants |
| 06/20/2013 | US20130158246 Optimized promoter sequence |
| 06/20/2013 | US20130158244 Modular Functional Peptides for the Intracellular Delivery of Nanoparticles |
| 06/20/2013 | US20130158240 Method Of Extracting A Fraction From A Biological Sample |
| 06/20/2013 | US20130158105 Conformation-selective nucleic acid inhibitors of ampa glutamate receptors |
| 06/20/2013 | US20130158102 Compositions and Methods for Inhibiting Expression of a Gene from the JC Virus |
| 06/20/2013 | US20130158099 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis |
| 06/20/2013 | US20130158097 Compositions and methods directed to treating liver fibrosis |
| 06/20/2013 | US20130157879 Biomarker dact1 for gastric cancer |
| 06/20/2013 | US20130157275 Oligonucleotide marker and method for identifying the same |
| 06/20/2013 | US20130157263 Methods and compositions for seamless cloning of nucleic acid molecules |
| 06/20/2013 | US20130156776 Compositions and methods for treating cancer and modulating stress granule formation |
| 06/20/2013 | US20130156762 Mechanically-Activated Cation Channels |
| 06/20/2013 | DE102011121238A1 Einzeldomänen-antikörper gegen clostridium difficile toxine Single-domain antibodies against Clostridium difficile toxins |
| 06/19/2013 | EP2605013A1 Stimulation of pancreatic beta-cell proliferation |
| 06/19/2013 | EP2604703A2 Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| 06/19/2013 | CN103157103A Functional influenza virus-like particles (vlps) |
| 06/19/2013 | CN102174538B Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 06/18/2013 | US8466352 Inbred maize variety PH18WY |
| 06/18/2013 | US8466351 Inbred maize variety PH18KJ |
| 06/18/2013 | US8466350 Tomato line FIS 14-2100 |
| 06/18/2013 | US8466344 Plant transcription factors |
| 06/18/2013 | US8466342 Early endosperm promoter and methods of use |
| 06/18/2013 | US8466341 Maize 17KD oleosin seed-preferred regulatory element |
| 06/18/2013 | US8466274 RNAi therapeutic for treatment of hepatitis C infection |
| 06/18/2013 | US8466273 Hepatitis C virus inhibitors |
| 06/18/2013 | US8466272 Probe set and method for identifying HLA allele |
| 06/18/2013 | US8466271 Regulatory elements |
| 06/18/2013 | US8466269 Covalent tethering of functional groups to proteins and substrates therefor |
| 06/18/2013 | US8466268 Lactobacillus sp. JNU2116 with antimutagenic activity |
| 06/18/2013 | US8466258 Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| 06/18/2013 | US8466124 RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 06/18/2013 | US8466122 Trialkyl cationic lipids and methods of use thereof |
| 06/18/2013 | US8466121 Method of selectively inhibiting the activity of ACAT1 in the treatment of Alzheimer's disease |
| 06/18/2013 | US8466120 Oligomeric compounds and compositions for use in modulation of pri-miRNAs |
| 06/18/2013 | US8466118 Modulation of blood brain barrier protein expression |
| 06/18/2013 | US8466117 Compositions and methods for modulating angiogenesis |
| 06/18/2013 | US8466116 Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
| 06/18/2013 | US8466106 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
| 06/18/2013 | US8465966 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA |
| 06/18/2013 | US8465965 Reagents and methods for cyanobacterial production of bioplastics and biomaterials |
| 06/18/2013 | US8465958 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/18/2013 | US8465957 Alpha-amylase variants |
| 06/18/2013 | US8465953 Ethanol production in non-recombinant hosts |
| 06/18/2013 | US8465952 Microorganism producing L-methionine precursor and the method of producing L-methionine precursor using the microorganism |
| 06/18/2013 | US8465951 Method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system |
| 06/18/2013 | US8465945 Method for production and use of mite group 1 proteins |
| 06/18/2013 | US8465942 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 06/18/2013 | US8465928 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof |
| 06/18/2013 | US8465923 Markers for diagnosis of pulmonary inflammation and methods related thereto |
| 06/18/2013 | US8465922 Methods and systems for monitoring reactions |
| 06/18/2013 | US8465921 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 06/18/2013 | US8465919 Method of detecting methylated cytosine |
| 06/18/2013 | US8465748 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2439042C Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/18/2013 | CA2415187C Dna vaccines encoding hiv accessory proteins |
| 06/13/2013 | WO2013086489A1 Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositons and methods |
| 06/13/2013 | WO2013086008A1 Methods and products for transfecting cells |
| 06/13/2013 | WO2013033234A9 Molecular markers associated with aphid resistance in soybean |
| 06/13/2013 | WO2008016988A9 Methods of nonspecific target capture of nucleic acids |
| 06/13/2013 | US20130150570 Nuclease resistant double-stranded ribonucleic acid |
| 06/13/2013 | US20130150569 Bicyclic nucleosides and oligomeric compounds prepared therefrom |
| 06/13/2013 | US20130150428 Mir27b is a novel target for treatment of liver fibrosis |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | US20130150265 Chemical synthesis using up-converting phosphor technology and high speed flow cytometry |
| 06/13/2013 | US20130150263 Human t2r nucleic acid sequences |
| 06/13/2013 | US20130150248 Arrays of Nucleic Acid Probes for Analyzing Biotransformation Genes |
| 06/13/2013 | US20130149772 Magnetic ion-exchange resin and method for the preparation thereof |
| 06/13/2013 | US20130149699 Translation Kinetic Mapping, Modification and Harmonization |
| 06/13/2013 | US20130149691 Methods, Reagents and Kits for Preservation of Nucleic Acids in Biological Samples |
| 06/13/2013 | US20130149371 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 06/13/2013 | CA2858382A1 Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositons and methods |
| 06/13/2013 | CA2858148A1 Methods and products for transfecting cells |
| 06/12/2013 | EP2601204A2 Modified nucleosides and oligomeric compounds prepared therefrom |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN103154245A Antisense nucleic acid |
| 06/12/2013 | CN103154015A Method for improving detection of b cell immunoglobulin gene recombination |
| 06/12/2013 | CN103154014A Modified nucleosides and oligomeric compounds prepared therefrom |
| 06/12/2013 | CN103153314A 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN102167737B Swine immune trait related protein and encoding gene as well as application thereof |
| 06/12/2013 | CN101918556B Cell permeable NM23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 06/11/2013 | US8461436 Plants and seeds of corn variety CV741729 |
| 06/11/2013 | US8461326 SiRNA targeting connective tissue growth factor (CTGF) |
| 06/11/2013 | US8461325 Oligomers |
| 06/11/2013 | US8461324 Compositions and methods for detection of hepatitis A virus nucleic acid |
| 06/11/2013 | US8461323 Characterization of granulocytic ehrlichia and methods of use |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461319 Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 06/11/2013 | US8461318 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeutics |
| 06/11/2013 | US8461317 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| 06/11/2013 | US8461316 Nanoparticles for delivery of bioactive agents |
| 06/11/2013 | US8461315 MicroRNAs and uses thereof |
| 06/11/2013 | US8461314 Nucleic acid sequences for biosynthesis of non-MccJ25-related lariat peptides |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | US8461301 Synthetic dragline spider silk-like proteins |